Methyl 3-(3-(tert-butyl)-4-hydroxyphenyl)propanoate, 97.0%, 25g

(1R,7R)-4-Dimethylamino-9,9-dimethyl-2,2,6,6-tetrakis(3,5-dimethylphenyl)-3,5,8,10-tetraoxa-4-phosphabicyclo[5.3.0]decane, 95%, 250mg

1,1-DIFLUORO-6-AZASPIRO[2.5]OCTANE HCL, 95.0%, 10g

Dimethyl 5-nitroisophthalate, 95.0%, 500g

3-(1,3-Oxazol-5-yl)benzoic acid, 97.0%, 5g

ethyl 2-(3,4-dichlorophenyl)ethanecarboximidate hydrochloride, 95.0%, 10g

Tert-butyl n-[3-(piperidin-4-yloxy)propyl]carbamate, 95%, 50mg

Spiro[3.3]heptane-2,6-diol, 97%, 250mg

(S)-2-((tert-Butoxycarbonyl)amino)-3-(quinolin-2-yl)propanoic acid, 95.0%, 1g

3-Amino-5-methoxy-pyridine, 97.0%, 5g

2,3-Dibromopropan-1-amine hydrobromide, 95+%, 25mg

Phasenkontrastschlitten mit Phaseneinstellung für Planphasenobjektive PLPH 10x und S40x

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-nitrophenyl)propanoic acid, 95.0%, 1g